FOXL2: a central transcription factor of the ovary

被引:119
|
作者
Georges, Adrien [1 ,2 ]
Auguste, Aurelie [1 ,2 ]
Bessiere, Laurianne [1 ,2 ]
Vanet, Anne [1 ,2 ]
Todeschini, Anne-Laure [1 ,2 ]
Veitia, Reiner A. [1 ,2 ]
机构
[1] Inst Jacques Monod, CNRS, UMR 7592, F-75013 Paris, France
[2] Univ Paris 07, Univ Paris Diderot, Paris, France
关键词
cancer; oestrogen receptors; ovary; ovarian function; FOXL2; GRANULOSA-CELL TUMORS; PRIMARY FOLLICLE TRANSITION; ANTI-MULLERIAN HORMONE; BETA-SUBUNIT TRANSCRIPTION; MAMMALIAN OVARY; SEX-REVERSAL; FORKHEAD TRANSCRIPTION; GENE-EXPRESSION; MOUSE OVARY; IN-VITRO;
D O I
10.1530/JME-13-0159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Forkhead box L2 (FOXL2) is a gene encoding a forkhead transcription factor preferentially expressed in the ovary, the eyelids and the pituitary gland. Its germline mutations are responsible for the blepharophimosis ptosis epicanthus inversus syndrome, which includes eyelid and mild craniofacial defects associated with primary ovarian insufficiency. Recent studies have shown the involvement of FOXL2 in virtually all stages of ovarian development and function, as well as in granulosa cell (GC)-related pathologies. A central role of FOXL2 is the lifetime maintenance of GC identity through the repression of testis-specific genes. Recently, a highly recurrent somatic FOXL2 mutation leading to the p. C134W subtitution has been linked to the development of GC tumours in the adult, which account for up to 5% of ovarian malignancies. In this review, we summarise data on FOXL2 modulators, targets, partners and post-translational modifications. Despite the progresses made thus far, a better understanding of the impact of FOXL2 mutations and of the molecular aspects of its function is required to rationalise its implication in various pathophysiological processes.
引用
收藏
页码:R17 / R33
页数:17
相关论文
共 50 条
  • [21] The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells
    Georges, Adrien
    L'Hote, David
    Todeschini, Anne Laure
    Auguste, Aurelie
    Legois, Berangere
    Zider, Alain
    Veitia, Reiner A.
    ELIFE, 2014, 3 : 1 - 19
  • [22] Aromatase inhibition reduces expression of FOXL2 in the embryonic chicken ovary
    Hudson, QJ
    Smith, CA
    Sinclair, AH
    DEVELOPMENTAL DYNAMICS, 2005, 233 (03) : 1052 - 1055
  • [23] The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome
    Laura Crisponi
    Manila Deiana
    Angela Loi
    Francesca Chiappe
    Manuela Uda
    Patrizia Amati
    Luigi Bisceglia
    Leopoldo Zelante
    Ramaiah Nagaraja
    Susanna Porcu
    M. Serafina Ristaldi
    Rosalia Marzella
    Mariano Rocchi
    Marc Nicolino
    Anne Lienhardt-Roussie
    Annie Nivelon
    Alain Verloes
    David Schlessinger
    Paolo Gasparini
    Dominique Bonneau
    Antonio Cao
    Giuseppe Pilia
    Nature Genetics, 2001, 27 : 159 - 166
  • [24] FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary
    Nolan, Amber
    Joseph, Nancy M.
    Sangoi, Ankur R.
    Rabban, Joseph
    Zaloudek, Charles
    Garg, Karuna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2017, 36 (06) : 568 - 574
  • [25] The Transcriptional Targets of Mutant FOXL2 in Granulosa Cell Tumours of the Ovary
    Shelling, A. N.
    Rosario, R.
    Araki, H.
    Print, C. G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S130 - S130
  • [26] Conventional and unconventional interactions of the transcription factor FOXL2 uncovered by a proteome-wide analysis
    Penrad-Mobayed, May
    Perrin, Caroline
    Herman, Laetitia
    Todeschini, Anne-Laure
    Nigon, Fabienne
    Cosson, Bertrand
    Caburet, Sandrine
    Veitia, Reiner A.
    FASEB JOURNAL, 2020, 34 (01): : 571 - 587
  • [27] The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome
    Crisponi, L
    Deiana, M
    Loi, A
    Chiappe, F
    Uda, M
    Amati, P
    Bisceglia, L
    Zelante, L
    Nagaraja, R
    Porcu, S
    Ristaldi, MS
    Marzella, R
    Rocchi, M
    Nicolino, M
    Lienhardt-Roussie, A
    Nivelon, A
    Verloes, A
    Schlessinger, D
    Gasparini, P
    Bonneau, D
    Cao, A
    Pilia, G
    NATURE GENETICS, 2001, 27 (02) : 159 - 166
  • [28] The forkhead factor FOXL2: A novel tumor suppressor?
    Benayoun, Berenice A.
    Kalfa, Nicolas
    Sultan, Charles
    Veitia, Reiner A.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1805 (01): : 1 - 5
  • [29] A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation
    Caburet, S
    Demarez, A
    Moumné, L
    Fellous, M
    De Baere, E
    Veitia, RA
    JOURNAL OF MEDICAL GENETICS, 2004, 41 (12) : 932 - 936
  • [30] Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles
    L'Hote, David
    Georges, Adrien
    Todeschini, Anne Laure
    Kim, Jae-Hong
    Benayoun, Berenice A.
    Bae, Jeehyeong
    Veitia, Reiner A.
    HUMAN MOLECULAR GENETICS, 2012, 21 (14) : 3264 - 3274